Aetiology and pathogenesis of ulcerative colitis. Still more questions than clear answers
Review articleGastroent Hepatol 2011; 65(2): 56-64.
Summarypdf Milan Lukáš, Martin BortlíkWhich non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?
CommentGastroent Hepatol 2011; 65(3): 159-160.
pdf Martin Bortlík, Milan LukášSingle-balloon enteroscopy in patients with Crohn's disease - single centre's experience
Original articleGastroent Hepatol 2011; 65(4): 215-219.
Summarypdf Naděžda Machková, Martin Bortlík, Eva Bouzková, Dana Ďuricová, Luděk Hrdlička, Milan LukášProton-pump inhibitors - up to date
Review articleGastroent Hepatol 2011; 65(6): 331-342.
Summarypdf Jan Martínek, Milan LukášJournal at the beginning of 66th annual volume: the current state and perspectives
EditorialGastroent Hepatol 2012; 66(1): 7-8.
pdf Milan Lukáš, Irena KratochvílováLow serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2012; 66(1): 23-31.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Viktor Komárek, Naděžda Machková, Arnošt Komárek, Ivana Janatková, Milan LukášNew standards in Crohn's disease treatment
NewsGastroent Hepatol 2012; 66(1): 68-70.
pdf Pavel Drastich, Milan LukášAnalysis of volatile compounds in the breath of patients with inflammatory bowel diseases
Original articleGastroent Hepatol 2012; 66(2): 125-130.
Summarypdf Luděk Hrdlička, Kseniya Dryahina, Dana Ďuricová, Martin Bortlík, Naděžda Machková, Patrik Španěl, Milan Lukáš